Alistair Cook

960 total citations
30 papers, 691 citations indexed

About

Alistair Cook is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Alistair Cook has authored 30 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 10 papers in Immunology. Recurrent topics in Alistair Cook's work include Occupational and environmental lung diseases (16 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Pleural and Pulmonary Diseases (9 papers). Alistair Cook is often cited by papers focused on Occupational and environmental lung diseases (16 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Pleural and Pulmonary Diseases (9 papers). Alistair Cook collaborates with scholars based in Australia, United Kingdom and United States. Alistair Cook's co-authors include Anna K. Nowak, Richard Lake, W. Joost Lesterhuis, Alison M. McDonnell, Martin A. Ebert, Suki Gill, Synat Keam, Clare Blackburn, Tanya L. Medley and Kathy E. O’Neill and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and The Lancet Oncology.

In The Last Decade

Alistair Cook

27 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alistair Cook Australia	13	310	254	239	110	74	30	691
Joris D. Veltman Netherlands	11	346 1.1×	288 1.1×	293 1.2×	117 1.1×	25 0.3×	21	732
Piera Maiolino Italy	17	452 1.5×	104 0.4×	409 1.7×	244 2.2×	48 0.6×	47	915
Ravi Medikonda United States	10	186 0.6×	74 0.3×	170 0.7×	138 1.3×	63 0.9×	33	534
Jinen Song China	10	222 0.7×	63 0.2×	157 0.7×	159 1.4×	44 0.6×	14	439
Ioannis Vamvakaris Greece	10	268 0.9×	168 0.7×	101 0.4×	159 1.4×	14 0.2×	35	530
Fuqiang Dai China	11	318 1.0×	213 0.8×	364 1.5×	263 2.4×	24 0.3×	21	793
Francesca Scordamaglia Italy	13	370 1.2×	107 0.4×	513 2.1×	99 0.9×	13 0.2×	20	747
Guido Pelosi Italy	7	289 0.9×	39 0.2×	299 1.3×	72 0.7×	55 0.7×	9	623
Jubrail Dahabreh Greece	12	348 1.1×	191 0.8×	274 1.1×	159 1.4×	7 0.1×	28	615
Collin M. Labak United States	11	169 0.5×	78 0.3×	104 0.4×	181 1.6×	32 0.4×	36	504

Countries citing papers authored by Alistair Cook

Since Specialization

Citations

This map shows the geographic impact of Alistair Cook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alistair Cook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alistair Cook more than expected).

Fields of papers citing papers by Alistair Cook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alistair Cook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alistair Cook. The network helps show where Alistair Cook may publish in the future.

Co-authorship network of co-authors of Alistair Cook

This figure shows the co-authorship network connecting the top 25 collaborators of Alistair Cook. A scholar is included among the top collaborators of Alistair Cook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alistair Cook. Alistair Cook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keam, Synat, Suki Gill, Pejman Rowshanfarzad, et al.. (2025). Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma model. Cancer Immunology Immunotherapy. 74(2). 44–44. 2 indexed citations

McNeish, Iain A., Davide Radice, Rosemary Lord, et al.. (2025). 1064O ICON8B: GCIG phase III randomised trial comparing first-line weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy + bevacizumab in high-risk stage III-IV epithelial ovarian cancer (EOC): Final overall survival (OS) analysis. Annals of Oncology. 36. S668–S669.

Keam, Synat, et al.. (2022). Effects of Photon Radiation on DNA Damage, Cell Proliferation, Cell Survival, and Apoptosis of Murine and Human Mesothelioma Cell Lines. Advances in Radiation Oncology. 7(6). 101013–101013. 7 indexed citations

Cook, Alistair, Alison M. McDonnell, Michael Millward, et al.. (2021). A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers. Expert Review of Anticancer Therapy. 21(5). 465–474.

Nowak, Anna K., Wee Loong Chin, Synat Keam, & Alistair Cook. (2021). Immune checkpoint inhibitor therapy for malignant pleural mesothelioma. Lung Cancer. 162. 162–168. 6 indexed citations

Cook, Alistair, Michael Millward, Alison M. McDonnell, et al.. (2021). Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors. Scientific Reports. 11(1). 15312–15312. 16 indexed citations

Keam, Synat, Suki Gill, Martin A. Ebert, Anna K. Nowak, & Alistair Cook. (2020). Enhancing the efficacy of immunotherapy using radiotherapy. Clinical & Translational Immunology. 9(9). e1169–e1169. 52 indexed citations

Nowak, Anna K., Solenn Brosseau, Alistair Cook, & Gérard Zalcman. (2020). Antiangiogeneic Strategies in Mesothelioma. Frontiers in Oncology. 10. 126–126. 31 indexed citations

Nowak, Anna K., W. Joost Lesterhuis, Peey‐Sei Kok, et al.. (2020). Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in. The Lancet Oncology. 21(9). 1213–1223. 115 indexed citations

10.

Cook, Alistair, Louis Boon, Ian M. Dick, et al.. (2019). Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment. OncoImmunology. 8(11). e1641390–e1641390. 26 indexed citations

11.

Chee, Jonathan, Mark Watson, Abha Chopra, et al.. (2018). Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors. BMC Research Notes. 11(1). 864–864. 13 indexed citations

12.

Cook, Alistair, et al.. (2018). EBUS-TBNA Cytology Specimens are Predictive of Occupational Dust Exposure in Patients With Bilateral Mediastinal and Hilar Lymphadenopathy. Journal of Occupational and Environmental Medicine. 60(10). 880–885.

13.

McDonnell, Alison M., Alistair Cook, B. W. Robinson, Richard Lake, & Anna K. Nowak. (2017). Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters. BMC Cancer. 17(1). 417–417. 9 indexed citations

14.

Ulyanchenko, Svetlana, Kathy E. O’Neill, Tanya L. Medley, et al.. (2016). Identification of a Bipotent Epithelial Progenitor Population in the Adult Thymus. Cell Reports. 14(12). 2819–2832. 78 indexed citations

15.

Cook, Alistair, W. Joost Lesterhuis, Anna K. Nowak, & Richard Lake. (2015). Chemotherapy and immunotherapy: mapping the road ahead. Current Opinion in Immunology. 39. 23–29. 110 indexed citations

16.

Cook, Alistair, Alison M. McDonnell, Richard Lake, & Anna K. Nowak. (2015). Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. OncoImmunology. 5(3). e1066062–e1066062. 52 indexed citations

17.

Nowak, Anna K., Alistair Cook, Alison M. McDonnell, et al.. (2015). A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma. Annals of Oncology. 26(12). 2483–2490. 75 indexed citations

18.

Embleton-Thirsk, Andrew, Timothy Perren, Alistair Cook, et al.. (2015). 2748 Assessment of associations between disease stage and toxicity with bevacizumab (BEV) in ICON7, a phase III trial of front-line carboplatin/paclitaxel (CP) ± BEV for ovarian cancer (OC). European Journal of Cancer. 51. S546–S546. 1 indexed citations

19.

Cook, Alistair, et al.. (2000). A Survey of Methohexitone Use by Anesthetists in the Clinical Practice of ECT in Edinburgh. Journal of Ect. 16(4). 350–355. 9 indexed citations

20.

Cook, Alistair, et al.. (1996). Comparison of mitozantrone and epirubicin in advanced breast cancer. Clinical Oncology. 8(6). 363–366. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact